Photo taken from Neogene Therapeutics/LinkedIn
Dec 5, 2023, 12:48
Sarah’s expertise will be instrumental in helping us advance our mission of bringing potentially transformational TCR-T’s to patients – Neogene Therapeutics
Neogene Therapeutics announced on their LinkedIn:
“Today, we are spotlighting one of our exceptional new leaders at Neogene, Sarah Cohen, Vice President of Clinical Development. With over 16 years of clinical and industry experience in developing much-needed treatments, including those for cancer, Sarah’s expertise will be instrumental in helping us advance our mission of bringing potentially transformational TCR-T’s to patients.”
Source: Neogene Therapeutics/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 20, 2024, 17:05
Dec 20, 2024, 16:47
Dec 20, 2024, 16:44
Dec 20, 2024, 16:40
Dec 20, 2024, 16:39
Dec 20, 2024, 16:01
Dec 20, 2024, 15:57